Preexposure Prophylaxis (PrEP)
13
1
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 13 trials
100.0%
+13.4% vs benchmark
8%
1 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (13)
Clinical Decision Support for PrEP
Nurse-Led PrEP Initiation Among Incarcerated Individuals
SIRI Checklist: An Integrated Hospital Model to Optimize HIV Prevention in Persons Who Inject Drugs
Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana
eSTEP: An Integrated mHealth Intervention to Engage High-risk Individuals Along the Full PrEP Care Continuum
A Self-administered PrEP Decisional Aid for Dissemination With HIV Self-test Kits (DASH)
California MEPS Hub
Peer-led Community-based PrEP Delivery Among Youth in Brazil
Impact of Nursing Involvement on Implementation of HIV Prevention Services
Filling Gaps in the HIV Pre-exposure Prophylaxis Cascade Through Counseling
Pre-exposure Prophylaxis (PrEP) Rapid Access
PrEPared-RN, CAN Nurse-Led Management of High-risk Patients for Pre-Exposure Prophylaxis (PrEP)
A Study Evaluating An Integrated Pharmacy Digital Diary and Delivery Strategy to Increase PrEP Use Among MSM and TGW